Published in Strahlenther Onkol on July 01, 1989
Mouse models of sarcomas: critical tools in our understanding of the pathobiology. Clin Sarcoma Res (2012) 0.89
Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery. Expert Opin Drug Discov (2013) 0.78
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol (1997) 2.23
Informatics and medicine--from molecules to populations. Methods Inf Med (2008) 2.13
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Contiguous pattern spreading in patients with Hodgkin's disease. Radiother Oncol (1998) 1.55
Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys (1999) 1.51
O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med (2000) 1.48
Radiation induced CNS toxicity--molecular and cellular mechanisms. Br J Cancer (2001) 1.44
Radiotherapy for treatment of localized gastrointestinal non-Hodgkin's lymphoma. Radiother Oncol (1997) 1.43
Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial. Br J Cancer (2008) 1.42
A comparison of treatment results for recurrent malignant gliomas. Cancer Treat Rev (2000) 1.42
Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. Int J Radiat Oncol Biol Phys (2001) 1.38
Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 1.34
Immune surveillance of mouse brain perivascular spaces by blood-borne macrophages. Eur J Neurosci (2001) 1.33
DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol (2013) 1.32
Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects. J Clin Oncol (1999) 1.20
Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys (2000) 1.17
Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1993) 1.16
Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biology. Int J Radiat Biol (2002) 1.14
[Prevention, diagnosis, therapy, and follow-up of lung cancer]. Pneumologie (2010) 1.14
Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo. Oncogene (2006) 1.13
Induction treatment before surgery for non-small cell lung cancer. Lung Cancer (2003) 1.12
Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer (1996) 1.11
Impact of localized radiotherapy on blood immune cells counts and function in humans. Radiother Oncol (1999) 1.10
Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol (1996) 1.09
Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial. Eur J Surg Oncol (2004) 1.06
Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer? Eur J Nucl Med Mol Imaging (2005) 1.06
Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie (2010) 1.06
Methods for analysis of censored tumor growth delay data. Radiat Res (1990) 1.05
Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer. Lung Cancer (2006) 1.04
Tumor hypoxia, p53, and prognosis in cervical cancers. Int J Radiat Oncol Biol Phys (2001) 1.04
Radiation-induced gastrointestinal toxicity. Pathophysiology, approaches to treatment and prophylaxis. Strahlenther Onkol (1998) 1.01
Gastric Cancer. Curr Probl Surg (1997) 1.00
Rapid detection of radiation-induced chromosomal aberrations in lymphocytes and hematopoietic progenitor cells by mFISH. Mutat Res (2000) 1.00
Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status? Clin Oncol (R Coll Radiol) (2009) 1.00
DEGRO practical guidelines: radiotherapy of breast cancer III--radiotherapy of the lymphatic pathways. Strahlenther Onkol (2014) 0.99
Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis. Oncogene (2000) 0.99
Wild-type, mitochondrial and ER-restricted Bcl-2 inhibit DNA damage-induced apoptosis but do not affect death receptor-induced apoptosis. J Cell Sci (2001) 0.99
Predictive value of the tumor oxygenation by means of pO2 histography in patients with advanced head and neck cancer. Strahlenther Onkol (2001) 0.99
Targeting of Rad51-dependent homologous recombination: implications for the radiation sensitivity of human lung cancer cell lines. Br J Cancer (2005) 0.98
Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol (2008) 0.97
Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL. Oncogene (2001) 0.97
Radiotherapy with or without chemotherapy in the treatment of anal cancer: 20-year experience from a single institute. Strahlenther Onkol (2012) 0.97
Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma. Strahlenther Onkol (2013) 0.96
Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease. Eur J Med Res (2010) 0.96
One life saved by four prevented recurrences? Update of the Early Breast Cancer Trialists confirms: postoperative radiotherapy improves survival after breast conserving surgery. Strahlenther Onkol (2012) 0.95
Radiation sensitivity of lymphocytes from healthy individuals and cancer patients as measured by the comet assay. Radiat Environ Biophys (2001) 0.94
Repopulation capacity during fractionated irradiation of squamous cell carcinomas and glioblastomas in vitro. Int J Radiat Oncol Biol Phys (1997) 0.94
FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy. Eur J Nucl Med Mol Imaging (2002) 0.94
Squamous cell carcinoma and Zenker diverticulum. Dis Esophagus (2007) 0.93
Current concepts in stereotactic radiosurgery - a neurosurgical and radiooncological point of view. Eur J Med Res (2009) 0.93
Thermoradiotherapy for locally recurrent breast cancer with skin involvement. Int J Hyperthermia (2001) 0.93
Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors. Eur J Nucl Med Mol Imaging (2006) 0.93
Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice. J Cancer Res Clin Oncol (2001) 0.93
Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients. Gynecol Oncol (2007) 0.92
Radioresponsiveness of human glioma, sarcoma, and breast cancer spheroids depends on tumor differentiation. Int J Radiat Oncol Biol Phys (1993) 0.92
In vivo radiation sensitivity of glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1995) 0.92
No evidence for a different RBE between pulsed and continuous 20 MeV protons. Radiat Res (2009) 0.91
Caspase-2 is required for DNA damage-induced expression of the CDK inhibitor p21(WAF1/CIP1). Cell Death Differ (2011) 0.91
DEGRO practical guidelines: radiotherapy of breast cancer II: radiotherapy of non-invasive neoplasia of the breast. Strahlenther Onkol (2014) 0.91
[Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version]. Pneumologie (2011) 0.91
Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission : results of a multivariate analysis. Strahlenther Onkol (2012) 0.91
Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapy. Eur J Med Res (2011) 0.90
Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice. Cancer Res (1993) 0.90
Salvage radiotherapy in patients with recurrent esophageal carcinoma. Strahlenther Onkol (2012) 0.90
The effectiveness of 20 mev protons at nanosecond pulse lengths in producing chromosome aberrations in human-hamster hybrid cells. Radiat Res (2011) 0.90
Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical oesophagus. Oncology (1999) 0.90
The p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma irradiation-induced apoptosis and mediates senescence via RSK- and p53-independent accumulation of p21WAF1/CIP1. Cell Death Dis (2013) 0.89
Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial. Br J Cancer (1999) 0.88
From heart to heart for breast cancer patients - cardiovascular toxicities in breast cancer radiotherapy. Strahlenther Onkol (2013) 0.88
Prediction of very short survival in patients with brain metastases from breast cancer. Clin Oncol (R Coll Radiol) (2008) 0.88
New and recurrent tumor foci following local treatment as well as external beam radiation in eyes of patients with hereditary retinoblastoma. Graefes Arch Clin Exp Ophthalmol (1990) 0.88
Radiation-induced changes in breathing frequency and lung histology of C57BL/6J mice are time- and dose-dependent. Strahlenther Onkol (2012) 0.87
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma. Bone Marrow Transplant (2003) 0.87
Evaluation of the tissue toxicity of antiseptics by the hen's egg test on the chorioallantoic membrane (HETCAM). Eur J Med Res (2010) 0.87
The role of prophylactic cranial irradiation in the treatment of lung cancer. Lung Cancer (2001) 0.87
Three-dimensional imaging of whole mouse models: comparing nondestructive X-ray phase-contrast micro-CT with cryotome-based planar epi-illumination imaging. J Microsc (2013) 0.87
Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour. Eur Respir J (2006) 0.87
Blood flow and oxygenation status of human tumors. Clinical investigations. Strahlenther Onkol (1999) 0.87
Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus. Dis Esophagus (2013) 0.86
Radiation response in 10 high-grade human soft tissue sarcoma xenografts to photons and fast neutrons. Int J Radiat Oncol Biol Phys (1990) 0.86
Unilateral keloid formation after bilateral breast surgery and unilateral radiation. Eur J Med Res (2007) 0.86
Postoperative radiotherapy of spinal and intracranial ependymomas: analysis of prognostic factors. Radiother Oncol (1997) 0.86
Multifocal epithelioid hemangioendothelioma: case report of a clinical chamaeleon. Eur J Med Res (2006) 0.86
Neoadjuvant chemoradiotherapy of stage III non-small-cell lung cancer. Lung Cancer (2000) 0.86
Gene expression of circulating tumour cells and its correlation with tumour stage in breast cancer patients. Eur J Med Res (2009) 0.86
Time management in radiation oncology: evaluation of time, attendance of medical staff, and resources during radiotherapy for prostate cancer: the DEGRO-QUIRO trial. Strahlenther Onkol (2013) 0.86
The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation. Oncogene (1999) 0.86